Page 39
Volume 2
Journal of Medical Biotechnology
Biotechnology 2018
July 16-17, 2018
World Biotechnology Congress
July 16-17, 2018 Berlin, Germany
J Med Biotechnol 2018, Volume 2
Evaluation of the efficacy of recombinant pollen and fruit allergens by ELISA and immune-blotting
Mohammad Fereidouni and Afshin Derakhshani
Birjand University of Medical Sciences, Iran
Introduction & Aim:
Allergenic extracts from different sources extensively use for the diagnosis and treatment of allergic disorders.
However, the potency and stability of commercial natural extract is vary and in some cases dramatically decrease by time mostly
due to inherent enzyme activities producing recombinant allergens is proposed as an alternative method which can provide enough
allergens and improves stability and potency of allergens. Among different methods for expressing the allergenic proteins, the
E. coli
system is the first-choice for the initial screening of as it can be easily manipulated, cultured inexpensively and grows rapidly. The aim
of this study was to evaluate the potency of some recombinant allergens with natural extract by ELISA and immune-blotting methods.
Method:
Recombinant major allergens of melon, grape,
Chenopodium album
and
Salsola kali
pollen were expressed in
E. coli
,
lyophilized and purified by gel extraction. Total protein content was measured by Bradford method and after adjustment of the
concentration with commercial natural extract; the potency of extracts was assessed by ELISA and immune-blotting methods using
patients’ sera.
Results:
The potency of pollen recombinant allergens was comparable with natural extracts but for grape and melon, the potency
was better than natural extracts. With increasing the concentration of major allergens in extracts, the potency of extracts increased
accordingly.
Conclusion:
Recombinant allergens particularly for fruits which are unstable are the suitable alternative sources and can use in
in
vitro
and
in vivo
diagnostic methods for allergy evaluation.
Dr.m.fereidouni@gmail.com